Metraipolis › archive › dc_5992bcc407ef
Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients — Europe PMC PMID:40547037
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40547037
- DOI
- 10.3389/fimmu.2025.1573365
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-10T00:10:04.210Z
- SHA-256 of the archived text
37158e482fd4e0ad07a4a493c42edc672dac627e5cd39da7418b992e2f6e9015- Stable URL of this page
https://metraipolis.com/documento/dc_5992bcc407ef
How to cite
Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients — Europe PMC PMID:40547037 — Europe PMC (en), https://europepmc.org/article/MED/40547037 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5992bcc407ef (Metraipolis archive dc_5992bcc407ef, sha256 37158e482fd4e0ad07a4a493c42edc672dac627e5cd39da7418b992e2f6e9015)
BibTeX
@misc{dc5992bcc407ef,
title = {Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients — Europe PMC PMID:40547037},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40547037},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5992bcc407ef; sha256 37158e482fd4e0ad07a4a493c42edc672dac627e5cd39da7418b992e2f6e9015},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40547037. Agents can read the archived copy with the MCP tool read_document.